Radionuclide-based molecular imaging allows CAR-T cellular visualization and therapeutic monitoring

Chimeric antigen receptor T cell (CAR-T) therapy is a new and effective form of adoptive cell therapy that is rapidly entering the mainstream for the treatment of CD19-positive hematological cancers because of its impressive effect and durable responses. Huge challenges remain in achieving similar s...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Fuqiang, Long, Yu, Ji, Hao, Jiang, Dawei, Lei, Ping, Lan, Xiaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171102/
https://www.ncbi.nlm.nih.gov/pubmed/34093854
http://dx.doi.org/10.7150/thno.56989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171102/
https://www.ncbi.nlm.nih.gov/pubmed/34093854
http://dx.doi.org/10.7150/thno.56989

Ejemplares similares